Arcturus Therapeutics Files Definitive Proxy Statement
Ticker: ARCT · Form: DEF 14A · Filed: Apr 25, 2025 · CIK: 1768224
| Field | Detail |
|---|---|
| Company | Arcturus Therapeutics Holdings Inc. (ARCT) |
| Form Type | DEF 14A |
| Filed Date | Apr 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, annual-meeting
Related Tickers: ARCT
TL;DR
Arcturus (ARCT) filed its proxy statement for the June 6 meeting. Vote your shares!
AI Summary
Arcturus Therapeutics Holdings Inc. filed its definitive proxy statement (DEF 14A) on April 25, 2025, for its annual meeting on June 6, 2025. The filing details information for shareholders regarding the company's operations and governance, including proposals to be voted on at the meeting. Arcturus Therapeutics is a biotechnology company focused on developing RNA-based medicines.
Why It Matters
This filing provides shareholders with crucial information to make informed voting decisions on company matters, impacting the future direction and governance of Arcturus Therapeutics.
Risk Assessment
Risk Level: medium — Proxy statements are routine filings, but the specific proposals and shareholder votes can significantly impact a company's strategic direction and stock performance.
Key Numbers
- DEF 14A — Filing Type (Definitive Proxy Statement)
Key Players & Entities
- Arcturus Therapeutics Holdings Inc. (company) — Registrant
- 0001193805-25-000561 (filing_id) — Accession Number
- 20250425 (date) — Filing Date
- 20250606 (date) — Meeting Date
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with information required in a proxy statement for the annual meeting of shareholders.
When is the shareholder meeting scheduled?
The shareholder meeting is scheduled for June 6, 2025.
Who is the registrant filing this document?
The registrant filing this document is Arcturus Therapeutics Holdings Inc.
What is the filing date of this proxy statement?
The filing date of this proxy statement is April 25, 2025.
What is the standard industrial classification for Arcturus Therapeutics Holdings Inc.?
The standard industrial classification for Arcturus Therapeutics Holdings Inc. is Pharmaceutical Preparations [2834].
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 25, 2025 regarding Arcturus Therapeutics Holdings Inc. (ARCT).